Kemira holds a total of 1,411,299 own shares.
Share buyback programs
Kemira announced its second share buyback program on February 12, 2026, and the program commenced on February 13, 2026. Before this share buyback program Kemira held a total of 896,004 own shares. During the program there might be a slight delay in updating this page. Please visit Kemira’s news room to see the latest stock exchange releases.
The first share buyback program was conducted between July 22, 2025 and December 16, 2025.
More information on the share buyback programs can be found here.
Earlier announcements
March 4, 2026 stock exchange release
Kemira conveyed a total of 314,703 treasury shares without consideration to 70 key employees participating in the performance period 2023–2025 of the Performance Share Plan 2022–2026.The shares were conveyed to the participants on March 4, 2026.
The directed share issue is based on the authorization granted to the Board of Directors by the Annual General Meeting held on March 20, 2025. The Board of Directors decided on the transfer on February 11, 2026.
May 6, 2025 stock exchange release
Kemira transferred 12,344 shares to the members of the Board of Directors as part of remuneration of the Board, based on the decision of the Annual General Meeting of Kemira Oyj on March 20, 2025.
Share repurchase authorization
The Annual General Meeting 2025 authorized the Board of Directors to decide upon repurchase of a maximum of 14,600,000 company’s own shares (“Share repurchase authorization”).
Shares shall be repurchased by using unrestricted equity either through a tender offer with equal terms to all shareholders at a price determined by the Board of Directors or otherwise than in proportion to the existing shareholdings of the company’s shareholders (directed repurchase).
The price paid for the shares repurchased through a tender offer under the authorization shall be based on the market price of the company’s shares in public trading so that the minimum price to be paid shall be the lowest market price of the share quoted in public trading during the authorization period and the maximum price the highest market price quoted during the authorization period.
The price paid for the shares repurchased through directed repurchase under the authorization shall be based on the share price formed in public trading on the date of the repurchase or otherwise a price formed on the market.
Shares shall be acquired and paid for in accordance with the rules of Nasdaq Helsinki Ltd and the rules of Euroclear Finland Ltd as well as other applicable regulations.
Shares may be repurchased to be used in implementing or financing mergers and acquisitions, developing the company’s capital structure, improving the liquidity of the company’s shares or to be used for the payment of the annual fee payable to the members of the Board of Directors or implementing the company’s share-based incentive plans. In order to realize the aforementioned purposes, the shares acquired may be retained, transferred further or cancelled by the company.
The Board of Directors shall decide upon how the shares are repurchased and other terms related to any share repurchase.
The Share repurchase authorization is valid until September 20, 2026.
Share issue authorization
The Annual General Meeting 2025 authorized the Board of Directors to decide to issue through one or several share issues new shares and/or transfer company’s own shares held by the company, provided that the number of shares thereby issued and/or transferred totals a maximum of 15,600,000 shares (“Share issue authorization”).
The new shares may be issued and the company’s own shares held by the company may be transferred either for consideration or without consideration.
The new shares may be issued and the company’s own shares held by the company may be transferred to the company’s shareholders in proportion to their current shareholdings in the company, or by disapplying the shareholders’ pre-emption right, through a directed share issue, if the company has a weighty financial reason to do so, such as financing or implementing mergers and acquisitions, developing the capital structure of the company, improving the liquidity of the company’s shares or, if it is justified, for the payment of the annual fee payable to the members of the Board of Directors or implementing the company’s share-based incentive plans. The directed share issue may be carried out without consideration only in connection with the implementation of the company’s share-based incentive plans.
The subscription price of new shares shall be recorded to the invested unrestricted equity reserves. The consideration payable for the company’s own shares shall be recorded to the invested unrestricted equity reserves.
The Board of Directors shall decide upon other terms related to the share issues.
The Share issue authorization is valid until May 31, 2026.